Back to MORGAN STANLEY MORGAN STANLEY

ELDNELDN
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ELEDON PHARMACEUTICALS INC

MORGAN STANLEY holds 485,092 shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $1.9M as of 2026-Q2. The position was increased (+234.2% shares). ELDN represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$1.9M

Current Shares

485,092

Total Value Change

+$1.7M

Total Shares Change

+401,621

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
485,092
+234.2%
$1.9M0.0%$3.94
42
2026-Q1
Decreased
145,158
-39.6%
$447,0860.0%$2.50
0
2025-Q4
Increased
240,545
+0.6%
$363,2230.0%$1.51
16
2025-Q3
Decreased
239,159
-30.8%
$619,4230.0%$2.54
0
2025-Q2
Increased
345,629
+55.7%
$936,6550.0%$2.69
35
2025-Q1
Increased
221,957
+27.2%
$752,4340.0%$3.35
31
2024-Q4
Increased
174,506
+109.1%
$718,9650.0%$4.14
40
2024-Q3
Increased
83,471
+3773.4%
$207,8430.0%$2.49
25

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used